Prokidney (PROK) Other financing activities (2021 - 2026)

Prokidney's (PROK) quarterly Other financing activities came in at $211000.0 in Q1 2026, down 57.29% on a QoQ basis from $494000.0 in Q4 2025.

Prokidney (PROK) Other financing activities (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 4 years of Other financing activities data on file, last reported at $211000.0 in Q1 2026.

  • On a quarterly basis, Other financing activities changed N/A year-over-year to $211000.0 in Q1 2026; TTM through Mar 2026 was $845000.0, a 99.66% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, up 862.86% from the prior year.
  • Other financing activities for Q1 2026 stood at $211000.0, down from $494000.0 in the prior quarter.
  • Over the last five years, Other financing activities for PROK reached as high as $494000.0 in Q4 2025 and fell as low as $140000.0 in Q4 2024.
  • Historically, Other financing activities has averaged $281666.7 across 3 years, with a median of $211000.0 in 2026.
  • On a YoY basis, Other financing activities climbed as much as 252.86% in 2025 and fell as far as 252.86% in 2025.
  • Year by year, Other financing activities stood at $140000.0 in 2024, then surged by 252.86% to $494000.0 in 2025, then slumped by 57.29% to $211000.0 in 2026.
  • Per Business Quant data, the three most recent Other financing activities figures were $211000.0 in Q1 2026, $494000.0 in Q4 2025, and $140000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Prokidney 96.00 Mn 96.00 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 211,000.00
Mar 31, 2026 211,000.00
Dec 31, 2025 494,000.00
Dec 31, 2025 494,000.00
Dec 31, 2024 140,000.00
Dec 31, 2024 140,000.00
Dec 31, 2021 6.40 Mn
Dec 31, 2021 6.40 Mn
Sep 30, 2021 245.60 Mn
Sep 30, 2021 245.60 Mn